Cindy Orser

Op-ed on a new study related to how cannabidiol (CBD) exerts its clinical efficacy.

The cannabis industry is constrained by the continued use of acronyms and nonstandard abbreviations for strain naming in lieu of a scientific-based standardized classification convention or lexicon. Applying chemometric tools can result in not only the authentication of a given cannabis cultivar but also provide a quality control mechanism for both cannabis flower and any resulting cannabis-based drugs.

This article is intended to spark conversations about measurement uncertainty that lead to the recognition and application of effective uncertainty budgets in the cannabis arena.